Immunome (IMNM) Interest Coverage Ratio (2019 - 2026)

Immunome (IMNM) posted Interest Coverage Ratio of 0.32 for Q1 2026, up 99.89% on a QoQ basis from 299.84 in Q4 2025, and up 99.81% year-over-year from 0.16 in Q1 2025.

Immunome (IMNM) Interest Coverage Ratio (2019 - 2026) Analysis & Trends

Immunome's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 0.32 for Q1 2026.

  • Quarterly Interest Coverage Ratio rose 99.81% year-over-year to 0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.29 (up 99.6% YoY) and the FY2025 annual result came in at 1.24, up 56.71% from the prior year.
  • Interest Coverage Ratio was 0.32 for Q1 2026 at Immunome, up from 299.84 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.32 in Q1 2026 and bottomed at 5915.81 in Q4 2023.
  • A 5-year average of 481.58 and a median of 4.96 in 2022 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2023 — Interest Coverage Ratio plunged 22083.35% — and 2026, when it jumped 99.81%.
  • Immunome's Interest Coverage Ratio stood at 26.67 in 2022, then plunged by 22083.35% to 5915.81 in 2023, then jumped by 95.31% to 277.49 in 2024, then retreated by 8.05% to 299.84 in 2025, then jumped by 99.89% to 0.32 in 2026.
  • Business Quant data shows IMNM's Interest Coverage Ratio at 0.32 in Q1 2026, 299.84 in Q4 2025, and 1.44 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Immunome 2.49 Bn 1.91 Bn - -0.32

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.32
Dec 31, 2025 -299.84
Sep 30, 2025 -1.44
Jun 30, 2025 -1.95
Mar 31, 2025 -169.08
Dec 31, 2024 -277.49
Sep 30, 2024 -0.77
Jun 30, 2024 -0.87
Mar 31, 2024 -1,322.99
Dec 31, 2023 -5,915.81
Sep 30, 2023 -0.41
Jun 30, 2023 -0.56
Mar 31, 2023 -44.71
Dec 31, 2022 -26.67
Sep 30, 2022 -2.51
Jun 30, 2022 -4.96
Mar 31, 2022 -116.54
Jun 30, 2021 -0.28
Mar 31, 2021 -38.97
Dec 31, 2020 -55.79